RealFeedApp beta

Exogenus developed a sustainable analytical panel

Researchers at Exogenus implemented a sustainable assay panel to manage the high variability of umbilical cord blood as raw material. The workflow enables producing non-conventional EV products without compromising quality control.

Field
tools and releases
What they did
Exogenus Therapeutics developed a simplified and sustainable assay panel for quality control of extracellular vesicle (EV) production derived from umbilical cord blood.
Why it matters
This enables companies to produce products using non-standard cell sources while maintaining quality control and avoiding complex screening methods.
#extracellular vesicles#quality control#umbilical cord blood#exogenus therapeutics

Read the original →